Transfusion Reactions in Emergency Medicine Treatment & Management
- Author: Eric M Kardon, MD, FACEP; Chief Editor: Barry E Brenner, MD, PhD, FACEP more...
Emergency Department Care
All patients receiving blood products should be placed on continuous cardiac monitoring and pulse oximetry.
- Hemolytic transfusion reaction
- Stop transfusion as soon as a reaction is suspected.
- Replace the donor blood with normal saline.
- Examine the blood to determine if the patient was the intended recipient and then send the unit back to the blood bank.
- Furosemide may be administered to increase renal blood flow.
- Low-dose dopamine may be considered to improve renal blood flow.
- Make efforts to maintain urine output at 30-100 mL/h.
- Extravascular hemolytic reactions do not require any specific treatment. However, if clinically ruling out intravascular hemolysis is difficult, follow the same treatment.
- Nonhemolytic transfusion reaction
- Aggressive treatment of simple febrile reactions is not necessary. However, because the nonspecific symptoms are similar to those of a hemolytic transfusion reaction, differentiating this entity from a hemolytic reaction is necessary.
- The transfusion should be terminated.
- Evaluate the patient for evidence of hemolysis.
- The patient's fever can be treated with acetaminophen.
- Anaphylactic reaction
- Stop the transfusion immediately.
- Support the airway and circulation as necessary.
- Administer epinephrine, diphenhydramine, and corticosteroids.
- Maintain intravascular volume.
- Minor allergic reaction
- Administer antihistamines.
- Although the necessity of stopping the transfusion is unclear, in more severe cases and in uncertain cases, the transfusion should be stopped.
- Transfusion-related acute lung injury[3]
- Monitor oxygen saturation.
- Provide supplemental oxygen to maintain oxygen saturation greater than 92%.
- Hypoxemia severe enough to require endotracheal intubation and positive-pressure ventilation occurs in 70-75% of patients.
- No evidence supports the routine use of corticosteroids.[4]
- The blood bank should be notified.
- GVH disease
- No effective therapies currently exist.
- Emphasis needs to be placed on prevention.
- Massive transfusion
- To decrease the risk of hypothermia in patients receiving massive transfusion, administer the blood through a blood warmer. Do not place blood in a microwave oven to warm, as this causes hemolysis.
- Do not administer platelets and fresh frozen plasma routinely or by using a formula based on the number of units of packed cells transfused. Only administer with evidence of abnormal bleeding associated with thrombocytopenia or an elevated PT or aPTT.
- Treat symptomatic hypocalcemia with calcium chloride or calcium gluconate.
Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. Aug 2009;49 Suppl 2:1S-29S. [Medline].
Fiebig EW, Busch MP. Emerging infections in transfusion medicine. Clin Lab Med. Sep 2004;24(3):797-823, viii. [Medline].
Triulzi DJ. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg. Mar 2009;108(3):770-6. [Medline].
Cherry T, Steciuk M, Reddy VV, Marques MB. Transfusion-related acute lung injury: past, present, and future. Am J Clin Pathol. Feb 2008;129(2):287-97. [Medline].
Dellinger EP, Anaya DA. Infectious and immunologic consequences of blood transfusion. Crit Care. 2004;8 Suppl 2:S18-23. [Medline].
Dodd RY, Leiby DA. Emerging infectious threats to the blood supply. Annu Rev Med. 2004;55:191-207. [Medline].
Goodnough LT. Risks of blood transfusion. Anesthesiol Clin North America. Jun 2005;23(2):241-52, v. [Medline].
Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest. Jul 2004;126(1):249-58. [Medline].
Spahn DR, Rossaint R. Coagulopathy and blood component transfusion in trauma. Br J Anaesth. Aug 2005;95(2):130-9. [Medline].
[Guideline] Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol. Dec 2006;135(5):634-41. [Medline].
Stainsby D, Russell J, Cohen H, Lilleyman J. Reducing adverse events in blood transfusion. Br J Haematol. Oct 2005;131(1):8-12. [Medline].
Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA. Mar 26 1997;277(12):967-72. [Medline].

